J&J effort to resolve talc lawsuits in bankruptcy fails a second time
[ad_1]
NEW YORK –
A U.S. judge on Friday shot down Johnson & Johnson’s second attempt to resolve tens of thousands of lawsuits over its talc products in bankruptcy, imperiling a proposed US$8.9 billion settlement that would stop new lawsuits from being filed.
U.S. Bankruptcy Judge Michael Kaplan in Trenton, N.J., ruled that J&J company’s second bankruptcy, like its first, must be dismissed because the company was not in “financial distress.”
J&J’s first bankruptcy gambit began in 2021, when it offloaded its talc liabilities into a new company, LTL Management, and immediately placed that company into bankruptcy.
LTL’s first bankruptcy was dismissed in April after a U.S. appeals court ruled that it was not in sufficient financial distress to be eligible for bankruptcy protection.
LTL quickly filed for bankruptcy again, arguing that its second effort has won more support from plaintiffs for a comprehensive settlement of current and future lawsuits alleging that J&J’s baby powder and other talc products sometimes contained asbestos and caused mesothelioma, ovarian cancer and other cancers. J&J has said its talc products are safe and do not contain asbestos.
Attorneys representing cancer victims, along with the U.S. Justice Department’s bankruptcy watchdog, had called for LTL’s second bankruptcy to be dismissed as an abuse of U.S. bankruptcy law. Cancer victims who oppose the bankruptcy settlement argued that the second bankruptcy recycles a failed legal strategy to keep their cases from being heard by juries.
J&J argued that the proposed bankruptcy settlement offers a fairer and faster resolution for cancer claimants than litigation in other courts. J&J compared recent trials to a “lottery” in which some litigants receive large awards and others get nothing. It said that the costs of its talc-related verdicts, settlements and legal fees have reached about US$4.5 billion.
Plaintiffs’ lawyers who opposed the US$8.9 billion offer said that J&J had created the “illusion” of support by signing deals with plaintiffs’ lawyers who quickly signed up large numbers of clients without ever filing any lawsuits against J&J.
By settling the lawsuits in bankruptcy, J&J could cram down the settlement terms on cancer victims opposed to the deal, and prevent new lawsuits from being filed by people who develop cancer in the future as a result of their talc use, according to lawyers opposed to the deal.
LTL’s bankruptcy proceedings have largely paused the 38,000 lawsuits that were filed before October 2021. Kaplan allowed one case to proceed to trial during LTL’s second bankruptcy, resulting in a US$18.8 million verdict in favour of a California man who said he developed cancer from exposure to J&J baby powder.
(Reporting by Dietrich Knauth in New York; Editing by Jonathan Oatis and Matthew Lewis)
[ad_2]